https://togopoliticsdaily.com/article/854929300-esperion-reaches-settlement-agreement-with-anda-filer-dr-reddy-s-laboratories-not-to-market-generic-versions-of-nexletol-bempedoic-acid-and
Esperion Reaches Settlement Agreement with ANDA Filer, Dr. Reddy’s Laboratories, Not to Market...
settlement agreementnot toesperionreachesanda
https://www.hcrx.com/portfolio-item/esperion/
Esperion - HealthCare Royalty
Apr 10, 2026 - PRODUCTSNEXLETOL®, NEXLIZET®, ENBUMYST® NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) are oral, non-statin therapies FDA approved to...
esperionhealthcareroyalty
https://www.getmidas.com/midasin-kulaklari/esperion-israilli-bir-sirketle-anlasma-imzaladi-p-74762
Esperion, İsrailli bir şirketle anlaşma imzaladı - Midas
Dec 12, 2024 - Esperion, İsrailli bir şirketle anlaşma imzaladı. En güncel borsa ve finans haberleri Midas'ta!
esperionbirmidas
https://www.northamericatoday.com/article/946364513-esperion-therapeutics-offers-short-term-option-for-diuretic-management-before-escalation-to-iv-for-patients-with-heart-failure
Esperion Therapeutics Offers Short-Term Option for Diuretic Management Before Escalation to IV for...
North America Today is an online news publication focusing on the United States: The top news stories from the United States
esperion therapeuticsshort termoffersoptiondiuretic
https://www.pharma-marketing.com/esperion-to-acquire-corstasis-to-add-enbumyst-to-its-cv-portfolio/
Esperion to acquire Corstasis and add Enbumyst – Pharma-Marketing.com
Esperion has agreed to acquire Corstasis for $75m upfront plus milestones and royalties, adding FDA-approved Enbumyst (bumetanide nasal spray).
esperionacquireaddenbumystpharma